对功能性高风险骨髓瘤的理性方法
Francesca Gay1, Giuseppe Bertuglia1, Roberto Mina1
1Division of Hematology 1, Clinical Trial Unit, AOU Città della Salute e della Scienza, Department of Molecular Biotechnology and Health Science, University of Torino, Torino, Italy.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
早期识别功能性高风险多发性骨髓瘤患者至关重要. 本综述解决了这些患者定义和管理这些患者的未满足需求,以改善生存结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 多发性骨髓瘤表现出显著的临床和生物异质性,影响患者的存活率.
- 目前的分期系统可能不足以确定所有高风险患者.
- 功能性高风险患者,定义为低于最佳的治疗反应,面临着不良预后.
研究的目的:
- 定义和描述功能性高风险多发性骨髓瘤患者.
- 对这一子集审查现有的风险因素和评分系统.
- 探索功能性高风险患者的潜在管理策略.
主要方法:
- 对多发性骨髓瘤的临床研究和评论的文献综述.
- 分析风险因素和预后评分系统.
- 探索治疗反应模式和结果.
主要成果:
- 功能性高风险多发性骨髓瘤的特点是早期复发或低于最佳反应,尽管潜在的标准基线风险因素.
- 现有的分期系统可能无法充分捕捉这些患者.
- 这一群人的生存率仍然很差,即使使用了当代疗法.
结论:
- 对于功能性高风险多发性骨髓瘤患者的及时识别和一致定义,存在着至关重要的未满足需求.
- 需要改进风险分层和有针对性的管理策略.
- 需要进一步研究这种患者子组的特征和最佳治疗方法.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.4K
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Kaplan-Meier Approach
150
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
150
